YZR Capital is a health tech fund investing in early-stage companies that drive technological advancements in healthcare to improve patient outcomes and system efficiency.
Reinhard is a founding partner at YZR and a professor of radiology. He previously founded TeleClinic and held clinical and academic roles in radiology.
The pre-seed round was led by YZR Capital to support clinical trials and platform development for eating disorder care.
"The widening gap between the need for care and available resources, along with the lack of personalised treatment options, urgently requires a radical rethink of how eating disorder care is provided. Our goal is to revolutionise care pathways, providing tools that empower clinicians and deliver meaningful results. We aim to keep people out of hospital and enable better long-term recovery while saving costs for the healthcare system. Univa’s platform will augment the overwhelmed clinical workforce by providing evidence-based tools to reach more patients and families, enabling earlier intervention, improved monitoring, and faster recovery."
The investment round was co-led by Aviva Ventures, YZR Capital, Oxford Capital, Triple Point Ventures and Simplyhealth Ventures to fund US expansion and new product development.
"Our investment in Scan.com is a statement of our intent to invest in promising young digital and tech firms – they are growing rapidly, have a unique customer proposition and are already leading the way on medical imaging services in the UK. We are really excited to support Scan.com’s development and growth."
The funding round was led by Triple Point Ventures with backing from StartUp Health, Plug and Play Ventures, and YZR Capital.
"We’re incredibly excited to use this latest round of funding to empower even more people to take their healthcare into their own hands, by making diagnostic imaging accessible to everyone, everywhere."
The seed round was co-led by Oxford Capital and YZR to fund expansion into international markets.
"Increasing access to the right diagnostic imaging and testing is vital to saving lives. It offers preventive healthcare that, if delayed, can cause significant problems to the patient and put even greater pressure on the healthcare system. In my role as an osteopath I've seen how the deterioration of patient wellbeing can be impacted by the cost and access of such tests. With this new investment we can continue to grow our network to get the tests that help to direct patients to the optimal therapy for the best outcome."
— Jasper Nissim, Co-Founder and UK Managing Director
